Physician profile
Adam C Morse
NPI 1255338059
$4,971.87
in general payments reported to CMS, 2019-2025
14 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,759 · 2020: $543 · 2021: $332 · 2022: $273 · 2023: $470 · 2024: $1,412 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,064.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,012.64 | 2019-2025 | Acufex, Microraptor, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Linvatec Corporation | $980.46 | 2019-2024 | Biobrace 23mm |
| Coastal Medical Technologies LLC | $728.24 | 2024-2025 | |
| Horizon Therapeutics Plc | $623.42 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $460.37 | 2020-2023 | Tricera Handpiece |
| Ferring Pharmaceuticals INC. | $365.12 | 2019-2024 | Euflexxa |
| Dunamis Medical, LLC | $255.17 | 2024 | |
| Vericel Corporation | $252.69 | 2019-2024 | Maci |
| Depuy Synthes Sales INC. | $72.31 | 2019-2022 | |
| Djo, LLC | $66.86 | 2019 | |
| Dynasplint Systems INC. | $58.48 | 2019 | |
| Pacira Therapeutics, INC. | $49.78 | 2019 | |
| Stryker Corporation | $27.54 | 2020 | |
| Anika Therapeutics, INC. | $18.79 | 2024 | Integrity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Morse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.